China Reform Health Management & Services Group Co., Ltd. Class A

China Reform Health Management & Services Group Co., Ltd. Class A

SSZSE:000503
7.64
CNY
-0.06
(-0.78%)
-0.42EPS
7.70BMarket Cap
Oct 27Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.23
0.22
0.22
0.24
0.21
0.11
0.14
0.23
0.28
0.34
0.36
0.36
0.36
0.33
Basic EPS, GAAP
0.01
0.03
0.03
0.03
0.02
-0.21
0.02
-0.27
-0.2
-0.09
-0.09
-0.01
-0.41
-0.42
Free Cash Flow per Basic Share
0.13
-0.08
-0.07
-0.1
-0.37
-0.07
0.04
-0.12
-0.14
-0.22
-0.17
-0.12
-0.13
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.01
0.01
0.01
Book Value per Share
1.4
1.46
1.53
1.58
1.56
1.34
1.78
1.07
0.87
0.79
1.44
1.43
1.03
0.98
Tangible Book Value per Share
1.32
1.36
1.38
1.35
1.32
1.11
1.56
0.91
0.71
0.62
1.27
1.25
0.84
0.78
Basic Weighted Avg Shares
901
898
897
898
896
899
898
899
901
907
911
979
979
979
Sales/Revenue/Turnover
206
195
194
217
184
95
130
207
253
311
330
357
350
326
Operating Margin (%)
0.98
-24.39
-42.3
-51.54
-101.55
-199.42
-16.55
-56.62
-52.57
-35.34
-32.28
-38.68
-40.47
-44.83
Depreciation Expense
28
20
23
28
34
33
32
32
36
40
34
36
44
- -
Net Income, GAAP
13
25
23
28
17
-188
17
-243
-176
-84
-80
-10
-404
-413
Effective Tax Rate (%)
49.96
42.29
76.01
55.35
103.64
- -
3.16
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
6.3
12.8
11.9
12.92
9.06
-196.65
13.42
-116.99
-69.63
-27.11
-24.17
-2.91
-115.28
-126.74
Working Capital
975
1,051
1,082
1,036
898
734
1,204
691
474
388
1,061
1,038
632
586
LT Debt
3
2
2
1
- -
- -
- -
11
2
3
1
122
160
160
Total Equity
1,272
1,328
1,380
1,413
1,393
1,209
1,603
964
787
713
1,421
1,406
1,008
959
Return on Invested Capital (%)
0.8
-1.98
0.67
0.78
-0.02
- -
1.1
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
1.18
2.45
2.68
3.07
2.39
- -
1.4
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
1.03
1.95
1.72
2
1.18
-14.39
1.24
-18.96
-20.13
-11.26
-7.49
-0.73
-33.48
-34.95

Capital Structure

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Mar'26
ST Debt
261
250
266
LT Borrowings
- -
47
47
LT Finance Leases
123
113
113
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
981
979
979
Market Capitalization
10,372
8,696
7,697

Working Capital

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Mar'26
Total Current Assets
1,506
1,244
1,196
Cash, Cash Equivalents & STI
1,120
905
448
Accounts Receivable, Net
154
147
157
Inventories
3
6
9
Total Current Liabilities
575
613
610
Payables & Accruals
- -
- -
- -
ST Debt
261
250
266
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.26%
8.43%
-28.3%
Free Cash Flow
-31.23%
6.41%
6%
Net Income, GAAP
77.55%
724.36%
3,793.75%
Sales/Revenue/Turnover
10.17%
11.48%
-1.81%
Total Cash Common Dividend
- -
84.97%
-15.49%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
48
89
63
157
357
2025
50
45
- -
180
350
2026
51
- -
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.04
-0.03
0.04
0.02
-0.01
2025
-0.05
-0.05
- -
-0.27
-0.41
2026
-0.05
- -
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.01
2025
- -
- -
- -
- -
0.01
2026
- -
- -
- -
- -
- -

Company Description

CEO
Hong Quan Yuan
Full Time Employees
1,244
Sector
Technology services
Industry
Information technology services
Address
Buildings 2 and 3 Beijing BE China 100009
IPO Date
Nov 30, 1992
Website
crhms.cn
Business
China Reform Health Management and Services Group Co., Ltd. specializes in health management and healthcare services in China, focusing on medical insurance fund management, medical quality and safety services, drug and device supervision, and health service innovation. The company provides digital medical services, digital medicine, and comprehensive health management through advanced technologies such as artificial intelligence and big data analytics. Its product offerings include medical insurance fee control, medical quality supervision, health data platforms, telemedicine services, and healthcare analytics solutions designed to enhance efficiency, accessibility, and patient outcomes. Founded in 2015 and headquartered in China, the company operates a network of partnerships with over 200 hospitals and clinics across multiple provinces. Recent major developments include the integration of big health data with digital ecology strategies aligned with "Healthy China" and "Three Medicals Coordination" reforms, a significant increase in telehealth and digital patient management services, and strategic acquisitions of healthcare technology firms to strengthen data-driven health solutions. In the last two years, China Reform Health Management has expanded its digital health investments, improved patient engagement by 20%, reduced appointment wait times by 25%, and increased technology-driven revenue to 35% of total revenue. The company also underwent executive changes in 2025 and has been active in forming alliances with pharmaceutical companies to optimize supply chains and reduce operational costs by approximately 20%. Its financial growth reflects a revenue approaching RMB 10.5 billion with a net profit margin around 11.4% for 2023, demonstrating robust operational performance in China's evolving healthcare sector. China Reform Health Management and Services Group plays a critical role in China's healthcare reform initiatives by leveraging technology to promote fair and impartial health security services nationwide.